Lysine residues near each end of the receptor ectodomain (in rat P2X 2 Lys 69 and Lys 308 ) have been implicated in ATP binding to P2X receptors. We recorded membrane currents from human embryonic kidney cells expressing P2X subunits and found that lysine-to-alanine substitutions at equivalent positions in the P2X 3 receptor (Lys 63 and Lys 299 ) also prevented channel function. Heteromeric P2X 2/3 receptors are formed when P2X 2 and P2X 3 subunits are expressed together; they can be distinguished by their relatively sustained response to ␣␤-methylene-ATP. By coexpression of wild-type P2X 3 and mutated P2X 2 subunit, we found that the heteromeric P2X 2/3 channel functioned normally when either lysine in the P2X 2 subunit was mutated to alanine (i.e., [K69A] or [K308A]) but not when both lysines were mutated to alanine (i.e., [K69A, K308A]). However, coexpression of wild-type P2X 2 with a mutated P2X 3 subunit ([K68A] or [K299A]) produced no functional heteromers. The rescue of the single lysine mutant P2X 2 subunit by wildtype P2X 3 (but not the converse) suggests that the heteromeric channel contains one P2X 2 and two P2X 3 subunits and that the receptor functions essentially normally as long as two subunits are not mutated. The failure to rescue function in the P2X 2 subunit with both lysines mutated by wild-type P2X 3 suggests that these residues from two different subunits interact in agonist binding or channel opening.
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The heteromeric P2X 2/3 receptor is of interest because of its predominant expression on a subset of primary afferent nerves involved in the sensation of chronic noxious damage (Jarvis, 2003) , visceral distension (Vlaskovska et al., 2001) , hypoxia (Gourine, 2005) , and taste (Finger et al., 2005) . A key role for these receptor subunits is supported by experiments using P2X 3 gene knockouts (Cockayne et al., 2000 (Cockayne et al., , 2005 , P2X 3 RNA suppression (Barclay et al., 2002; Honoré et al., 2002) , and pharmacological antagonists selective for P2X 3 subunit-containing receptors .
There is good evidence that P2X subunits form channels as trimers (Nicke et al., 1998; North, 2002; Jiang et al., 2003; Barrera et al., 2005) . Like other ligand-gated channels, P2X receptors can form by homo-or hetero-oligomeric assembly of subunits (for review, see North, 2002) . Although both P2X 2 and P2X 3 subunits are able to form homomeric channels, the heteromeric P2X 2/3 receptor that is also formed can be distinguished by its unique functional properties (Lewis et al., 1995) . P2X 2 receptors are activated by ATP but not by the analog ␣␤-methylene-ATP (␣␤meATP), and the current is largely sustained through a 2-s agonist application. P2X 3 receptors are activated by both ATP and ␣␤meATP, and the current desensitizes very rapidly (Ͻ100 ms). The current through heteromeric P2X 2/3 channels can be identified as the sustained component when ␣␤meATP is the agonist (Lewis et al., 1995) .
The molecular operation of P2X subunits is not well understood. Each receptor subunit has intracellular amino and carboxyl termini and two transmembrane domains (TM1: approximately residues 30 -50; TM2: approximately residues 330 -354) that are joined by an ectodomain of approximately 280 residues. The ectodomain is glycosylated and disulfidebonded. There are no obvious "canonical" ATP-binding amino acid sequences in the ectodomain. In the case of the P2X 2 homomeric receptor, two conserved ectodomain lysine resi-dues have been suggested to play a role in binding the negatively charged phosphate moiety of ATP (Lys  69 and Lys   308 in rat P2X receptor), but the evidence is most complete for Lys 69 (Jiang et al., 2000) . A similar role for the corresponding lysines has also been identified in the case of the P2X 1 receptor (Lys 68 and Lys 309 ; Ennion et al., 2000) . These lysines are situated approximately 20 amino acids from the outer end of each TM. Experiments on the P2X 1 receptor using partial agonists also suggest a role for aromatic residues Phe 185 and Phe 291 to coordinate the binding of the adenine ring of ATP Vial et al., 2004 ). An alternative model of ATP binding has been proposed by Yan et al. (2005) in the case of the P2X 4 receptor. This is based on secondary structure homology between part of the receptor (Lys 180 -Lys 326 ) and class II aminoacyl-tRNA synthetases (Freist et al., 1998) .
The experiments reported herein focused on the two juxtamembrane lysines proposed to take part in ATP binding. We have found that, for the heteromeric P2X 2/3 channel, their importance in channel function depends greatly on whether they are in the P2X 2 or the P2X 3 subunit.
Materials and Methods
Molecular and Cell Biology. Rat P2X receptor cDNAs were used as described previously (Jiang et al., 2000) . Mutations were introduced using QuikChange site-directed mutagenesis (Stratagene, La Jolla CA) and confirmed by sequencing. Wild-type and mutated receptors were transiently expressed in human embryonic kidney 293 cells using Lipofectamine 2000 (Invitrogen, San Diego CA) according to the manufacturer's instructions. Transfected cells were harvested and replated on glass coverslips 24 to 48 h after transfection and kept at 37°C for 18 to 48 h before electrophysiological recording. P2X 2 plasmid (0.2 g) was cotransfected with P2X 3 plasmid (1 g), these ratios having been established to produce equal amounts of protein when detected by Western blot with a common C-terminal epitope tag (Jiang et al., 2003) . Enhanced green fluorescent protein cDNA (0.1 g) was also included. Immunocytochemistry of transfected cells was as described, using a C-terminal EYMPME epitope (Jiang et al., 2000 (Jiang et al., , 2003 .
Electrophysiology. Whole-cell patch-clamp recordings were made at 19 to 22°C using a HEKA EPC9 amplifier (Heka, Lambrecht, Germany). The holding potential was Ϫ60 mV. Patch pipettes (3-6 M⍀) contained 145 mM NaCl, 10 mM HEPES, and 10 mM EGTA, pH adjusted to 7.3 with NaOH. The external solution contained 147 mM NaC1, 2 mM KC1, 2 mM CaC1 2 , 2 mM MgCl 2 , 10 mM HEPES, and 13 mM glucose, pH adjusted to 7.3 with NaOH. Both internal and external solutions were 290 to 310 mOsM. Agonists were applied using the RSC 200 rapid solution changer (Biologic Science Instruments, Grenoble, France), with flow-pipe tips approximately 150 m from cell. All chemicals were purchased from Sigma (Poole, UK) and were made up daily from aliquots stored at Ϫ20°C.
Results
Homomeric Channels. Previous work on homomeric human P2X 1 (Ennion et al., 2000) and rat P2X 2 (Jiang et al., 2000) receptors has indicated that Lys 69 and Lys 308 (rat P2X 2 numbering) are essential for channel function. We found that alanine substitution at the equivalent positions in the P2X 3 subunit also led to a nonfunctional homomeric channel. We observed no current with applications of ␣␤meATP (up to 1 mM; n ϭ 5) (Fig. 1) or ATP (up to 1 mM; n ϭ 7). Immunocytochemistry of transfected cells showed no difference in the pattern or distribution between wild-type and mutated subunits. Figure 1 also (Fig. 1) . However, coexpression of these two mutated receptors clearly did (Fig.  2) . The currents were small compared with wild-type P2X 2 currents (Ͼ600 pA/pF) but not obviously different in other properties (Fig. 2) . It was striking that coexpression of two "dead" subunits resulted in formation of a channel that was responsive to 100 or 300 M ATP. If we assume that neither mutation affects expression or assembly, then one would expect three eighths of all trimeric channels to be [K69A] 2 ⅐[K308A] and three-eighths to be [K69A]⅐[K308A] 2 . This result therefore indicates that the effects of these two point mutations are not independent. Fig. 1 . A, mutation of conserved ectodomain lysines causes loss of function at rat P2X receptors. Pairs of traces show currents at wild-type and lysine mutant receptors. Agonists were: for P2X 1 , ␣␤meATP (300 M); for P2X 4 , ATP (1 mM); and for P2X 7 , BzATP (300 M). Each was applied for 2 s. B, mutation of Lys 69 or Lys 308 at P2X 2 causes a loss of function (ATP, 1 mM), and equivalent mutations to Lys 63 and Lys 299 in P2X 3 have a similar effect (␣␤meATP, 300 M). Heteromeric Channels. For the P2X 2/3 receptors, there was a striking difference in the effect of a single point mutation of either of the lysine residues, depending whether it was present in the P2X 2 or P2X 3 subunit. The currents in cells expressing mutant P2X 2 receptors with wild-type P2X 3 subunits were essentially the same as those observed in wild-type heteromeric receptors (Fig. 3) . The ␣␤meATP concentrations giving half-maximal currents (EC 50 ) were: for P2X 2/3 wild-type, 27 Ϯ 3.3 M (n ϭ 5); for P2X 2 [K69A] ϩ P2X 3 , 22 Ϯ 2.6 M (n ϭ 5), and for P2X 2 [K308A] ϩ P2X 3 , 44 Ϯ 2.6 M (n ϭ 8) (the last two values are significantly different, p Ͻ 0.0001). In contrast, cells expressing wild-type P2X 2 with P2X 3 [K63A] subunits showed no currents in response to ␣␤meATP up to 100 M. At such high concentrations, P2X 2 homomeric receptors are sensitive to ␣␤meATP (n ϭ 5) (Fig. 3 ) (see also Jiang et al., 2003) , and the small current observed was presumably passing through such receptors. Likewise, coexpression of wild-type P2X 2 subunits with P2X 3 [K299A] gave no currents in response to ␣␤meATP (up to 100 M, n ϭ 6) (Fig. 3) . These results indicate that a wild-type P2X 3 subunit can rescue function when it enters a heteromer with a mutated P2X 2 subunit, but not vice versa.
This rescue did not occur when both ectodomain lysines were mutated in the same P2X 2 subunit. Coexpression of P2X 2 [K69A,K308A] with P2X 3 produced no sustained currents to ␣␤meATP (n ϭ 9) (Fig. 3) . However, a fast desensitizing current typical of homomeric P2X 3 receptors was usually observed (Fig. 3) . A schematic summary of the expression of the further P2X 2 and P2X 3 subunits (either wild-type or mutant) that were coexpressed, and the results of the functional studies, is shown in Fig. 4 .
Discussion
The two lysines that are the focus of the present study are very highly conserved among P2X subunits. Lys 69 is present in 41 of 43 vertebrate sequences (including seven human, seven rat, seven mouse, one guinea pig, three chick, two Xenopus laevis, one bullfrog, nine zebrafish, and six pufferfish); the zebrafish P2X 2 receptor has Asp at this position, and it cannot be activated by ATP when heterologously expressed (Kucenas et al., 2003) . This lysine is also present in the one invertebrate (schistosome) sequence that is known to operate as an ATP-gated channel (Agboh et al., 2004) . Lys 308 is even more highly conserved; it is found in all the above 44 sequences and in two of the five related Dictyostelium discoideum sequences. Of the eight positively charged residues in the P2X 2 receptor ectodomain, Lys 69 and Lys 308 are the two where replacement by alanine causes the greatest loss of channel function; even replacement by arginine results in more than 100-fold reduction in sensitivity to ATP (Jiang et al., 2000) . The present experiments confirm that the lysine in the first of these positions is critical also for function of other P2X receptors, including P2X 3 .
The heterotrimeric P2X 2/3 receptor must contain either one 4 . A, schematic illustration of the P2X 2 and P2X 3 subunits used, and summary results. Small solid circles indicate positions of lysine-to-alanine substitution near outer end of TM1 or TM2. B, schematic interpretation. Channels with two P2X 3 subunits and one P2X 2 subunit might provide two subunit contacts with two lysine residues (arrows, putative binding site) if only one of the P2X 2 lysines were substituted by alanine (left, middle) but would have only one such contact when P2X 2 subunit has both lysines changed to alanine. 1, tested with ATP; 2, tested with ␣␤meATP; 3, normal wild-type currents were 522 Ϯ 74 pA/pF (n ϭ 9; measured 200 ms after beginning superfusion); 4, dead indicates no detectable current (Ͻ2 pA/pF); 5, ATP also evoked a sustained current, suggesting that the involvement of these residues is not specific to ␣␤meATP. or two copies of the P2X 3 receptor subunit. The simplest interpretation of the one-way rescue of P2X 2 mutants by P2X 3 (but not vice versa; Fig. 3 ), is that the P2X 2/3 receptors activated by ␣␤meATP have two copies of P2X 3 and one copy of P2X 2 . In other words, a functional channel can be formed and activated by ␣␤meATP even though it contains one dead P2X 2 subunit (e.g., P2X 2 [K69A]) but no opening can be elicited from a receptor comprising two dead P2X 3 subunits with a wild-type P2X 2 subunit. The rescue of wild-type P2X 3 was complete in the case of P2X 2 [K69A] and slightly less so for P2X 2 [K308A] (Fig. 3) , indicating that the two P2X 2 lysines do not have precisely equivalent roles. This result contrasts with earlier findings in which a highly conserved intracellular C-terminal lysine was mutated (Chaumont et al., 2004) . This lysine is required in homomeric P2X 2 and P2X 3 receptors for retention in the plasma membrane. In that case, wild-type P2X 3 subunits could restore the appearance and retention in the membrane of mutant P2X 2 subunits (P2X 2 [K366A]), and this rescue was fully reciprocal because wild-type P2X 2 also restored the appearance of P2X 3 [K357A]) (Chaumont et al., 2004) . Taken together, these results imply that only a single wild-type subunit is needed for successful retention in the membrane, but two wild-type (P2X 3 ) subunits are needed for channel function. The conclusion that the functional heteromer contains two P2X 3 subunits and one P2X 2 subunit agrees well with the results of a completely independent approach in which subunits were joined by disulfide bonds between engineered cysteine substitutions at the outer ends of the TMs (Jiang et al., 2003) . The finding is also consistent with the observation that the limiting slope of the Hill plot for activation of the heteromeric P2X 2/3 receptor is close to two, whereas for the homomeric P2X 3 and homomeric P2X 2 receptors, it is close to three (Jiang et al., 2003) . However, the present analysis can not distinguish between different numbers of ligand binding sites and different degrees of intersubunit cooperativity in the heteromeric versus the homomeric channels.
Ectodomain Lysines in Heteromeric P2X
For the homomeric P2X 1 and P2X 2 receptors, there is evidence that Lys 69 and Lys 308 contribute to an ATP binding site (Ennion et al., 2000; Jiang et al., 2000; Roberts and Evans, 2004) . Therefore, our present finding that the heteromeric channel operates normally even though it incorporates a mutated P2X 2 subunit may be interpreted in this context. This would imply that a heterotrimeric P2X receptor could open from a less than fully liganded state. For example, the tetrameric ␣-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor (Rosenmund et al., 1998) and the pentameric glycine receptor (Beato et al., 2002) can open from less than fully liganded states. But other interpretations are possible. For example, the P2X 3 (though not P2X 2 ) subunit lysines may be critical for multimeric channel assembly. Or the mutation might impede the conformational change of gating: a lysine-to-alanine substitution in a single P2X 2 subunit of the trimer might provide insufficient energetic impediment, whereas two such independent substitutions in the P2X 3 subunits might prevent it completely.
We were surprised to find that cells cotransfected with P2X 2 [K69A,K308A] subunit and wild-type P2X 3 subunit produced no detectable heteromeric current (Fig. 3) . In other words, the wild-type P2X 3 subunits can rescue function in a channel containing a P2X subunit with a single mutation ([K69A] or [K308A]) (a dead P2X 2 ) but not in a channel containing both those mutations (a "double-dead" P2X 2 ). This could have a simple energetic explanation of the type introduced above; namely, both P2X 3 subunits become liganded by ␣␤meATP, but the mutations provide too great an energy barrier for opening to occur. Or it could indicate that the effects of the lysines are not independent and that an interaction occurs between Lys 69 and Lys 308 . This would be consistent with the finding that in homomeric P2X 2 receptors, ATP can elicit currents when P2X 2 [K69A] and P2X 2 [K308A] are coexpressed, but not when either is expressed alone.
If one assumes that at least two agonist binding sites are required for channel activation (see above, and Ding and Sachs, 1999; Jiang et al., 2003) , then these observations can be explained if both Lys 69 of one subunit and Lys 308 of another (or equivalent for the P2X 3 subunits) are needed at one ATP binding site. The presence of a dead P2X 2 subunit would still provide for two ␣␤meATP binding sites (Fig. 4B , left and middle), but a double-dead P2X 2 subunit would prevent ␣␤meATP binding at two sites and therefore prevent channel function (Fig. 4B, right) . The interpretation that the agonist site is contributed from two different subunits in a heteromeric channel has parallels with nicotinic acetylcholine receptors (Sine, 2002) . Moreover, P2X 2 subunits carrying mutations of an allosteric zinc binding site have been covalently joined in tandem from concatenated cDNAs; these experiments indicated that histidines from different subunits contribute to the zinc binding site (Nagaya et al., 2005) .
The conclusion that the ␣␤meATP binding sites forms at the P2X 3 /P2X 3 and P2X 2 /P2X 3 interfaces is consistent with the observations that both nucleotide (Virginio et al., 1998; Burgard et al., 2000) and non-nucleotide antagonists (Jarvis et al., , 2004 ) mostly fail to discriminate between P2X 3 homomeric receptors and P2X 2/3 heteromeric receptors. A more complete understanding of the agonist binding site will inform the further development of small molecules that act as competitive antagonists at the P2X 2/3 heteromeric receptors; such molecules are likely to have value as pain-relieving drugs.
